Page last updated: 2024-09-05

n-demethyltramadol and Neoplasms

n-demethyltramadol has been researched along with Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hiraide, T; Kawakami, J; Naito, T; Sato, H; Tanaka, H; Yamada, Y	1

Other Studies

1 other study(ies) available for n-demethyltramadol and Neoplasms

Article	Year
Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients. European journal of clinical pharmacology, 2018, Volume: 74, Issue:11 Topics: Administration, Oral; Aged; Analgesics, Opioid; Asian People; C-Reactive Protein; Cancer Pain; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Interleukin-6; Male; Middle Aged; Neoplasms; Time Factors; Tramadol	2018

Article

Year

Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients.

European journal of clinical pharmacology, 2018, Volume: 74, Issue:11

Topics: Administration, Oral; Aged; Analgesics, Opioid; Asian People; C-Reactive Protein; Cancer Pain; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Interleukin-6; Male; Middle Aged; Neoplasms; Time Factors; Tramadol

2018